133 related articles for article (PubMed ID: 38482704)
1. [Natural history of mucopolysaccharidosis type III in a series of Colombian patients].
Cabarcas L; Ramón JL; Espinosa E; Guerrero GP; Martínez N; Santamaría N; Lince I; Reyes S
Rev Neurol; 2024 Mar; 78(6):171-177. PubMed ID: 38482704
[TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients.
Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X
J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333
[TBL] [Abstract][Full Text] [Related]
3. Natural history of Sanfilippo syndrome in Spain.
Delgadillo V; O'Callaghan Mdel M; Gort L; Coll MJ; Pineda M
Orphanet J Rare Dis; 2013 Dec; 8():189. PubMed ID: 24314109
[TBL] [Abstract][Full Text] [Related]
4. A case report of Sanfilippo syndrome - the long way to diagnosis.
Lorenz D; Musacchio T; Kunstmann E; Grauer E; Pluta N; Stock A; Speer CP; Hebestreit H
BMC Neurol; 2022 Mar; 22(1):93. PubMed ID: 35291973
[TBL] [Abstract][Full Text] [Related]
5. [Sanfilippo Syndrome].
Osipova LA; Kuzenkova LM; Namazova-Baranova LS; Gevorkyan AK; Podkletnova TV; Vashakmadze ND
Vestn Ross Akad Med Nauk; 2015; (4):419-27. PubMed ID: 26710524
[TBL] [Abstract][Full Text] [Related]
6. Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period.
Lin HY; Chuang CK; Lee CL; Tu RY; Lo YT; Chiu PC; Niu DM; Fang YY; Chen TL; Tsai FJ; Hwu WL; Lin SJ; Chang TM; Lin SP
Am J Med Genet A; 2018 Sep; 176(9):1799-1809. PubMed ID: 30070758
[TBL] [Abstract][Full Text] [Related]
7. Sanfilippo syndrome: Overall review.
Andrade F; Aldámiz-Echevarría L; Llarena M; Couce ML
Pediatr Int; 2015 Jun; 57(3):331-8. PubMed ID: 25851924
[TBL] [Abstract][Full Text] [Related]
8. From hypertransaminasemia to mucopolysaccharidosis IIIA.
Krawiec P; Pac-Kożuchowska E; Mełges B; Mroczkowska-Juchkiewicz A; Skomra S; Pawłowska-Kamieniak A; Kominek K
Ital J Pediatr; 2014 Dec; 40():97. PubMed ID: 25439061
[TBL] [Abstract][Full Text] [Related]
9. The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
Bodamer OA; Giugliani R; Wood T
Mol Genet Metab; 2014; 113(1-2):34-41. PubMed ID: 25127543
[TBL] [Abstract][Full Text] [Related]
10. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
11. Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation.
Değerliyurt A; Yayıcı Köken Ö; Teker ND; Aktaş D
Neurocase; 2021 Aug; 27(4):366-371. PubMed ID: 34396902
[TBL] [Abstract][Full Text] [Related]
12. The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype.
Nijmeijer SCM; van den Born LI; Kievit AJA; Stepien KM; Langendonk J; Marchal JP; Roosing S; Wijburg FA; Wagenmakers MAEM
Orphanet J Rare Dis; 2019 Nov; 14(1):249. PubMed ID: 31718697
[TBL] [Abstract][Full Text] [Related]
13. Combined Hurler and Sanfilippo syndrome in a sibling pair.
Sun A; Hopwood JJ; Thompson J; Cederbaum SD
Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
[TBL] [Abstract][Full Text] [Related]
14. The first Korean case of mucopolysaccharidosis IIIC (Sanfilippo syndrome type C) confirmed by biochemical and molecular investigation.
Huh HJ; Seo JY; Cho SY; Ki CS; Lee SY; Kim JW; Park HD; Jin DK
Ann Lab Med; 2013 Jan; 33(1):75-9. PubMed ID: 23301227
[TBL] [Abstract][Full Text] [Related]
15. What Can We Learn from the Parents of Children Affected with Mucopolysaccharidosis Type III-A in Israel?
Liber S; Staretz-Chacham O; Kishon M; Pode-Shakked B; Chorin O; Kneller K; Anikster Y; Mangisto G; Saada A; Raas-Rothschild A
Mol Syndromol; 2022 Feb; 13(1):45-49. PubMed ID: 35221874
[TBL] [Abstract][Full Text] [Related]
16. Sanfilippo syndrome: a mini-review.
Valstar MJ; Ruijter GJ; van Diggelen OP; Poorthuis BJ; Wijburg FA
J Inherit Metab Dis; 2008 Apr; 31(2):240-52. PubMed ID: 18392742
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans and mucopolysaccharidosis type III.
Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
[TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene.
Liang Y; Gao X; Lu D; Zhang H; Zhang
Metab Brain Dis; 2023 Aug; 38(6):2013-2023. PubMed ID: 37014526
[TBL] [Abstract][Full Text] [Related]
19. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications.
Kuiper GA; Meijer OLM; Langereis EJ; Wijburg FA
Orphanet J Rare Dis; 2018 Jan; 13(1):2. PubMed ID: 29310675
[TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.
Valstar MJ; Bruggenwirth HT; Olmer R; Wevers RA; Verheijen FW; Poorthuis BJ; Halley DJ; Wijburg FA
J Inherit Metab Dis; 2010 Dec; 33(6):759-67. PubMed ID: 20852935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
